|
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Blood Test Promises to Find Single Cancer Cell Among Millions of Normal Ones"There's a lot of potential here, and that's why there's a lot of excitement." (Raritan, NJ)—Several news agencies this week have reported on an AP story about a "revolutionary" blood test that can spot a single cancer cell among millions of healthy ones. Since four large cancer centers will be using it in studies, and Johnson & Johnson has decided to bring it to the market, it signals great hope for early detection of the disease. "Measuring CTCs in metastatic breast cancer patients provides oncologists with an additional tool to help us better monitor patient outcomes," said one of the lead authors, Dr. Massimo Cristofanilli, associate professor in the Department of Breast Medical Oncology at The University of Texas M. D. Anderson Cancer Center. "The CellSearch(R) CTC test provides an early indication about patients' disease progression and overall survival." The CellSearch(R) test works by using antibodies that are joined to microscopic iron particles, called ferrofluid. These antibody/ferrofluid combinations attach very specifically to CTCs. Powerful magnets then draw the CTCs out of the blood sample and they are then stained with additional bio-molecules and chemicals so that they can be positively identified as CTCs. 
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Other Recent Articles from Breaking Christian News Parents Beware: Ex-Psychic Calls Disney's Latest Animated Kids' Movie 'Really Disturbing' Sports Columnist Resigns When Seattle Times Spikes His Piece Supporting Female Athletes AI Data Centers Are Becoming a Flash Point in the Midterm Election Fentanyl Deaths Plunge 22% Thanks to Trump Admin Crackdown on Deadly Drug Crisis: Fox Exclusive Christian Employers Win New Protections from EEOC Gender-Identity Mandates Undercover, O'Keefe Exposes Alaska Voting Loophole as Senator Murkowski Opposes SAVE America Act Supreme Court Allows Trump's White House Ballroom Construction to Continue for Now The White House Needs a Ballroom. The Left Just Hates Who's Building It Beijing Is Feeding Communist Propaganda to Kids in 100+ US Schools Iowa Candidate Points to Farming Practices as Root Cause of Rising Cancer Rates Minnesota: 23rd Defendant Sentenced to Prison in Feeding Our Future Fraud Scandal Prosecutors Fight for Death Penalty in Charlie Kirk Case Trump Declares 'Economic D-Day' against Iran's Islamic Regime Attorney: Baby Boy at the Center of Surrogacy Case Has Had His First Heart Surgery Faced With Legal Threat, Live Action Stands by the Word 'Killing' When Describing Abortion Outrage Erupts in Spain as Socialists Move to Wipe Out Centuries-Old Christian Holiday President Trump Honors Teen Lifeguard Who Saved Boy's Life |
Subscribe to
|
Notes excerpts from a PR Newswire release about the test, coined the CellSearch system: Measuring the change in circulating tumor cell (CTC) count can accurately predict the prognosis and survival in patients with metastatic breast cancer (MBC), according to a newly published report in the July 10, 2010 issue of the Journal of Clinical Oncology. The CellSearch(R) System is the first 510(k) diagnostic test used to automate the capture and detection of CTCs, tumor cells that have detached from solid tumors and entered the patient's blood. (Photo by: 
All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.
Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved
Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.
| Home | Store | Subscribe | Facebook | Article Archive |